Balyasny Asset Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
17,593
+13,195
+300% +$951K ﹤0.01% 1952
2025
Q4
$281K Buy
4,398
+678
+18% +$41.8K ﹤0.01% 2755
2025
Q3
$235K Sell
3,720
-177,875
-98% -$12.4M ﹤0.01% 2671
2025
Q2
$13.6M Buy
181,595
+177,238
+4,068% +$13.9M 0.02% 827
2025
Q1
$384K Sell
4,357
-423
-9% -$39.9K ﹤0.01% 2363
2024
Q4
$437K Sell
4,780
-197,685
-98% -$20.3M ﹤0.01% 2244
2024
Q3
$22.7M Sell
202,465
-802,467
-80% -$80.3M 0.04% 578
2024
Q2
$98.5M Buy
1,004,932
+248,092
+33% +$24.6M 0.17% 127
2024
Q1
$75.9M Buy
756,840
+552,548
+270% +$48.6M 0.13% 178
2023
Q4
$18.3M Sell
204,292
-405,513
-66% -$32.3M 0.03% 639
2023
Q3
$46.8M Sell
609,805
-248,014
-29% -$20.6M 0.1% 287
2023
Q2
$71.8M Buy
857,819
+76,350
+10% +$6.21M 0.16% 159
2023
Q1
$65.9M Buy
781,469
+777,728
+20,789% +$66.8M 0.17% 152
2022
Q4
$305K Buy
+3,741
New +$301K ﹤0.01% 1986
2021
Q4
Sell
-4,417
Closed -$445K 2329
2021
Q3
$445K Buy
+4,417
New +$487K ﹤0.01% 1510
2020
Q3
Sell
-129,726
Closed -$9.03M 1372
2020
Q2
$9.03M Buy
129,726
+97,375
+301% +$6.14M 0.08% 360
2020
Q1
$1.51M Sell
32,351
-203,423
-86% -$13.1M 0.02% 673
2019
Q4
$18.7M Sell
235,774
-21,656
-8% -$1.67M 0.11% 276
2019
Q3
$19M Buy
257,430
+82,146
+47% +$5.89M 0.13% 251
2019
Q2
$13.6M Buy
175,284
+61,489
+54% +$4.67M 0.09% 320
2019
Q1
$8.63M Sell
113,795
-548,023
-83% -$43.6M 0.06% 430
2018
Q4
$48.4M Buy
+661,818
New +$52.8M 0.35% 64
2018
Q1
Sell
-17,449
Closed -$1.62M 2029
2017
Q4
$1.62M Sell
17,449
-24,326
-58% -$2.21M 0.01% 1198
2017
Q3
$3.78M Sell
41,775
-121,613
-74% -$10.4M 0.01% 801
2017
Q2
$13.7M Sell
163,388
-5,204
-3% -$419K 0.06% 433
2017
Q1
$13.6M Sell
168,592
-64,160
-28% -$5.05M 0.06% 392
2016
Q4
$17.5M Buy
232,752
+160,483
+222% +$11.6M 0.09% 306
2016
Q3
$4.89M Buy
+72,269
New +$4.85M 0.03% 504
2014
Q3
Sell
-152,400
Closed -$13.3M 747
2014
Q2
$13.3M Buy
+152,400
New +$13.2M 0.15% 171

Other funds holding EMN

Balyasny Asset Management's EMN Position: Q1 2026 in Review

Balyasny Asset Management increased its Eastman Chemical (EMN) stake by 300% in Q1 2026, buying an estimated $951K and bringing the position to 17,593 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Balyasny Asset Management first reported a position in EMN in Q2 2014 and has held it in 29 quarters since. The position peaked at $98.5M in Q2 2024. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Balyasny Asset Management held 17,593 shares of Eastman Chemical worth $1.34M as of Q1 2026.
  • Balyasny Asset Management bought 13,195 Eastman Chemical shares in Q1 2026, an estimated $951K.
  • Eastman Chemical made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1952 holding.
  • Balyasny Asset Management first reported a position in Eastman Chemical in Q2 2014 and has held it in 29 quarters since.
  • Balyasny Asset Management's Eastman Chemical position peaked at $98.5M in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.